Rubella seroprevalence using residual samples from the South African measles surveillance program: a cross-sectional

N V Motaze1,2, L Makhathini1, S B Smit1

  • 1A Division of the National Health Laboratory Service, Centre for Vaccines and Immunology, National Institute for Communicable Diseases , Johannesburg, South Africa.

Insights

South Africa has not yet introduced rubella-containing vaccines (RCV). High rubella susceptibility is found in children under 16, with about 20% of adults aged 16-49 also susceptible, informing RCV introduction strategies.

Area of Science:

  • Immunology
  • Vaccinology
  • Public Health

Background:

  • South Africa has not incorporated rubella-containing vaccines (RCV) into its routine immunization program.
  • Assessing population immunity is crucial for effective vaccine introduction strategies.
  • Understanding rubella antibody seroprevalence and immunity gaps is essential for public health planning.

Purpose of the Study:

  • To determine the seroprevalence of rubella antibodies in South Africa across all age groups.
  • To identify and characterize immunity gaps related to rubella in the South African population.
  • To inform the strategic introduction of rubella-containing vaccines (RCV) in South Africa.

Main Methods:

  • Utilized residual serum samples from the national measles surveillance program (2016-2018).
  • Employed a commercial enzyme-linked immunosorbent assay (ELISA) to detect rubella immunoglobulin G (IgG) antibodies.
  • Conducted logistic regression analysis to identify factors associated with rubella susceptibility (IgG negative), including age, sex, and province.

Main Results:

  • Analyzed 6057 samples, revealing high rubella susceptibility in children aged 0-11 months (81.9%) and 1-5 years (71.5%).
  • Susceptibility decreased with age, with 40.9% in 6-10 year olds and 31.25% in 11-15 year olds.
  • Approximately 19.9% of individuals aged 16-49 years remained susceptible to rubella. Age and province of residence were significant predictors of susceptibility.

Conclusions:

  • The majority of individuals susceptible to rubella in South Africa are children under 16 years old.
  • A notable proportion (around 20%) of adults aged 16-49 years also exhibit rubella susceptibility.
  • These findings highlight critical immunity gaps that must be addressed during the introduction of rubella-containing vaccines (RCV).